For Life Sciences

SOLUTIONS FOR LIFE SCIENCES

Using Real-World Data to Drive Innovation in Burn Care

BData’s core product offering leverages its extensive data set and knowledge of the burn care space to provide deep insights to help you grow and improve your business.

Supporting the Total Product Lifecycle

BData's established data ecosystem organically supports clinical research within the burn and wound care space

Pre-Clinical Trial

BData collaborated with an industry partner to understand product usage patterns in burn patients. That visibility helped the team focus product and commercial planning around actual clinical use (not assumptions) and prioritize where deeper evidence could create the strongest positioning advantage.

An industry partner came to BData with an initial A/B trial design comparing their product to an alternative. Using BData’s real-world dataset, we showed that a credible control arm could be represented within existing data—meaning they could focus on building only the study arm. The result was a more efficient path than a standard CRO approach, with clear savings in time and cost while preserving the ability to tell a strong comparative story.

Clinical Trials

An Industry partner leveraged data from the national burn registry to support evidence tied to label expansion, including work connected to expanding into pediatrics. From a go-to-market standpoint, this opened a larger addressable population with credible support—giving commercial and medical teams stronger footing for adoption in a new segment.

FDA Approval / Label Expansion

BData partnered with an industry collaborator to collect product-specific usage data and link those data to real-world outcomes in support of post-market evidence generation for the partner’s product. This gave commercial and medical teams a more durable proof base to support adoption, respond to customer questions, and reinforce product value as use expands.

Post-Market Evidence Collection

Post-launch, an industry partner worked with BData to track how the product was being used across the country and patient profiles—by body region and burn depth—and translate those findings into a clearer provider-facing narrative. The outcome is a tighter “where we win” story that supports field conversations, reduces ambiguity in positioning, and reinforces confidence as use scales.

Post-Market Marketing

BData supported Industry Partner A with real-world performance work focused on length of stay (LOS) versus a matched cohort. For market access and commercialization, this kind of result helps tie the product to an operational outcome that matters to hospitals—supporting value conversations in terms providers and administrators recognize.

Real-World Product Performance

Industry Partner B used BData to evaluate outcomes like LOS and infection rates in real-world care. That evidence helps sharpen differentiation—showing whether the product is improving meaningful outcomes or reducing downstream burden—so teams can anchor adoption conversations in measurable impact rather than preference.

With Industry Partner C, BData supported launch and ongoing evaluation by adding specific data fields to reliably capture product use and enable comparison to a matched cohort over time. Commercially, that setup matters because it creates a repeatable way to track performance as adoption grows—so the story stays current and defensible, not frozen at launch.

An Industry Partner came to BData interested in understanding the burn care market to inform product design decisions. BData supported data delivery and provided analytic services to explore the data to help them understand the specific market opportunity.

Next Generation Product Development

Life Sciences Companies We’ve Partnered With

BData Solutions for Life Science Companies

Analytics Services

Get in-depth data on product utilization by category and key clinical treatment KPIs designed to help understand treatment successes and opportunities.

Learn More >

Post-Market Data Strategy

Leverage custom data sets from our proprietary BCQP to develop peer-reviewed publications to achieve post-market objectives. BData will partner with you to identify the exact data you need and create custom data sets to help you meet your objectives.

Learn More >

FDA’s Total Product Life Cycle (TPLC) Support

Leverage the BCQP’s proprietary, case-level real-world evidence (RWE), collected in collaboration with burn center clinicians and the American Burn Association (ABA), to support FDA's Total Product Life Cycle (TPLC) approach for generating clinical evidence for regulatory decision making.

Learn More >

Comprehensive Clinical Trial Success Program

Leveraging BCQP insights, BData partners with you to proactively identify study site risks and safeguards, monitor data collection and align study documents (e.g., protocol, monitoring plan, statistical analysis plan) with clinical practice.

Learn More >

Hybrid Real-World Evidence Replacement Study

We combine Real World Data (RWD) with prospective elements—to support patient replacement, augmentation, and comparator arm development—accelerating timelines, without sacrificing rigor.

Learn More >

Analytics Services

Leveraging the robust data in the Burn Center Quality Platform (BCQP), the standard “Analytics Services Subscription” reports utilization of products by categories and key clinical treatments KPIs designed to help understand treatment successes and opportunities.

This solution helps customers:

Generate executive-level insights to guide investment and alignment decisions
Understand the efficacy of your products in real world burn cases
Identify opportunities for new products or services
Conduct feasibility studies and hypothesis testing early in the product development lifecycle
Publish clinical studies using real world data, making the process more efficient

Key features:

Direct access to focused analytic resource with deep content expertise
Fast, targeted analytics using real-world data
Utilization detail on your product versus the market as a whole
Cohorts are clinically and commercially defensible
Bias—adjusted comparisons using industry-standard methods
Ability to conduct propensity matching and advanced matching techniques
Regular updates of the analysis as data is refreshed in the platform

Post-Market Data Strategy

Understanding opportunities for innovation to advance the treatment of burn patients can require a deeper dive into the data. BData will partner with you to identify the exact data you need from our proprietary BCQP and create custom data sets to help you meet your objectives.

This solution helps customers:

Key features:

FDA’s Total Product Life Cycle (TPLC) Support

We provide end‑to‑end support for retrospective observational studies that meet the rigor required for regulatory submissions and peer‑reviewed publications. Our team builds custom data sets, executes advanced analytics, and delivers strategic insights that help you validate—or challenge—your clinical hypotheses with confidence. Traditional study designs often require long recruitment and monitoring periods. Our retrospective model dramatically shortens the timeline, enabling you to move from research question to actionable results in a fraction of the typical duration—without compromising scientific rigor.

This solution helps customers:

Accelerate access to high‑quality, decision‑ready insights
Generate abstracts and presentations for relevant conferences
Generate peer-reviewed publications on burn-care products and solutions, raising awareness and driving growth
Create and submit required studies for regulatory approval

Key features:

Custom Data Set Creation: Purpose‑built data sets tailored to your research question, patient population, and clinical endpoints
Publication‑and Regulatory‑Ready Analytics: Comprehensive statistical analysis, including bias adjustment and a fully developed Statistical Analysis Plan (SAP) aligned with FDA and journal standards
Full Final Study Report: A clear, comprehensive report summarizing key findings, insights, and implications for clinical practice, publication, or regulatory review

Comprehensive Clinical Trial Success Program

Clinical trials are a critical part of the product development lifecycle. BData can support you in that process with data or by augmenting your team and running the full trial, start-up through close-out.

We will scope the project in close partnership with you – from site identification, to CRF and database development to overall monitoring of the study, and execution of the statistical analysis plan

This solution helps customers:

Key features:

Hybrid Real-World Evidence (RWE) Replacement Study

Our hybrid retrospective‑plus‑prospective study model provides a modern, FDA‑aligned alternative to traditional burn care clinical evidence generation. By combining real‑world data (RWD) with prospective elements, we support patient replacement, augmentation, and comparator arm development—accelerating timelines while maintaining scientific and regulatory rigor.

This solution helps customers:

Key features:

Multi‑Year Hybrid RWE Design
Integrated retrospective and prospective data collection with test, control, and comparator arms
Pre-specified statistical analysis plan governing all analyses and interim looks
Supports patient replacement or augmentation strategies now allowable under evolving FDA guidance

Explore the power of BData

Learn how BData’s data ecosystem can support your needs